EN DE
Watch MULTI-CHEM LIMITED for free: we tell you when fair value or trend changes.
Data-driven stock valuation

MULTI-CHEM LIMITED (AWZ) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of MULTI-CHEM LIMITED stock S$7.18, price S$2.43, upside +195.5%, quality 68 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology SG · ISIN SG1BA2000002

MC MULTI-CHEM LIMITED logo Broad data Nov 14, 2026

MULTI-CHEM LIMITED

AWZ · SG

Cheap (66% below fair value) and solid company, but falling price: meets 2 of 3 rules.

Get notified free when this changes
Fair value 7.18 SGD · Strongly undervalued 
Quality 68/100 
Low debt 
Generates free cash flow 
15.1% dividend yield · Sustainable
Ranks above peers (14/14) 
Broad data 
Even on cautious assumptions the value is 132% above the price (5.64 SGD). 
Mixed Growth (revenue 5y +6.4 %/yr in SGD) 
Thin margins · 3.9% net margin (TTM) 
Moderate moat 47/100 · thin data
Falling price (downtrend) 
⚠ Small free float
Watch MULTI-CHEM LIMITED for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

4.48 SGD 1.13 SGD Fair Value 7.18 SGD Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

60‑month range 1.13 SGD – 4.48 SGD · fair‑value band 5.64 SGD – 8.70 SGD · the 2.43 SGD price screens below the 7.18 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.

Follow MULTI-CHEM in your weekly email

Every Wednesday you see whether MULTI-CHEM is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Multi-Chem Limited, an investment holding company, distributes information technology (IT) products in Singapore, China, India, Vietnam, and internationally. It operates through two segments, Printed Circuit Board (PCB) Business and IT Business.

Show moreShow less

The company distributes hardware and software relating to internet and network products, as well as related installation, technical, and maintenance services. It also provides PCB related services to PCB fabricators.

In addition, the company distributes specialty chemicals; PCB-related materials and equipment such as non-woven brushes, tacky rollers, tack cloth/wipes, cleaning machine, automatic drills regrinding machine and x-ray inspection machine; and PCB manufacturers and rental of machines.

Further, it leases machines; offers software consultancy and implementation services and IT training courses; distributes IT security products; and provides professional, management, and administration services, as well as sells software licenses and hardware.

Multi-Chem Limited was incorporated in 1985 and is headquartered in Singapore.

Stock analysis

MULTI-CHEM LIMITED (AWZ) currently trades at 2.43 SGD, while our model-based Fair Value estimate is 7.18 SGD, implying the stock looks roughly 66% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 7.55 SGD per share, and 23 of the 26 models we run sit above the 2.43 SGD price.

Bear case: the Asset-Based group reads lowest at 1.15 SGD, and 3 of the 26 models stay below the price. Data coverage for this calculation is high.

Scenario range: 5.64 SGD (bear) to 8.70 SGD (bull), the price of 2.43 SGD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 68/100 (solid quality), in the Technology sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

MULTI-CHEM LIMITED reported revenue of 654M SGD in FY2025 versus 604M SGD in FY2021, a compound +2.0%/yr. Reported net income was 26.4M SGD in FY2025, compounding +1.5%/yr from FY2021.

Key figures

Market cap 219M SGD (≈ $170M) Micro · P/E ratio 8.1 · P/S ratio 0.31 · EPS (TTM) 0.3000 SGD · Net margin 3.9% · Return on equity 18.2% · Return on assets (EBIT) 8.5% (5-year average) · Operating margin 5.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 46% below its 52-week high and 23% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −1% fair-value upside, at 196%, AWZ screens cheaper than that median.

Fair Value models

Bear 5.64 SGD Fair Value 7.18 SGD Bull 8.70 SGD
Price 2.43 SGD · Upside +195.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 6.00 SGD 7.99 SGD 10.56 SGD 82
Growth DCF 6.05 SGD 7.81 SGD 9.96 SGD 80
Owner Earnings 5.11 SGD 6.74 SGD 8.84 SGD 78
All 26 models by family
DCF Models
FCF DCF 6.00 SGD 7.99 SGD 10.56 SGD 82
Owner Earnings 5.11 SGD 6.74 SGD 8.84 SGD 78
5Y Revenue Exit 4.72 SGD 6.29 SGD 8.20 SGD 74
5Y EBITDA Exit 5.47 SGD 7.66 SGD 10.12 SGD 76
5Y P/E Exit 6.31 SGD 9.19 SGD 12.14 SGD 71
10Y Revenue Exit 5.14 SGD 6.58 SGD 8.38 SGD 68
10Y EBITDA Exit 5.64 SGD 7.44 SGD 9.70 SGD 69
10Y P/E Exit 6.13 SGD 8.41 SGD 11.08 SGD 65
Earnings-Based
Graham-Dodd 2.00 SGD 5.60 SGD 7.37 SGD 65
Lynch FV 2.56 SGD 3.65 SGD 4.75 SGD 61
PEG = 1.0 2.56 SGD 3.65 SGD 4.75 SGD 57
EPV 3.17 SGD 3.45 SGD 3.68 SGD 74
Dividend Discount
Gordon GGM 1.97 SGD 3.54 SGD 4.88 SGD 68
DDM Multi-Stage 1.97 SGD 2.93 SGD 3.78 SGD 67
Multiples
P/E Multiple 6.16 SGD 8.22 SGD 10.27 SGD 63
P/S Multiple 3.74 SGD 4.99 SGD 6.24 SGD 58
P/B Multiple 1.38 SGD 1.84 SGD 2.30 SGD 55
EV/EBIT 6.87 SGD 8.79 SGD 10.71 SGD 66
EV/EBITDA 5.66 SGD 7.18 SGD 8.70 SGD 67
EV/Revenue 4.02 SGD 5.27 SGD 6.52 SGD 54
Asset-Based
NCAV (Graham) 0.7600 SGD 1.15 SGD 1.43 SGD 55
Growth DCF
Growth DCF 6.05 SGD 7.81 SGD 9.96 SGD 80
Rev-Margin DCF 4.72 SGD 6.36 SGD 8.20 SGD 74
Economic Profit
Residual Income 1.68 SGD 2.06 SGD 2.71 SGD 76
ROIC Compounder 3.25 SGD 3.64 SGD 4.02 SGD 72
Growth Earnings
Growth-Adj P/E 4.81 SGD 6.87 SGD 8.93 SGD 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 68/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 56
How much profit the company makes from its sales and capital
Quality Growth 35
Are margins and returns getting better?
Cashflow 64
Do the profits arrive as real cash?
Financial strength 88
Debt, balance sheet and risk of trouble
Investment 84
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 12
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 66/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−4.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.4%
Start year 2020 (pandemic). Over 10 years: +6.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.9%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+8.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+8.3%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.8.3% vs 10.5%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 4%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−16.7%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Singapore: IMF forecast 2.0% a year to 2030, 1.7% from 2016 to 2025) that is about −18.4% a year for the price.

Watch AWZ, get fair value alerts →

Compare MULTI-CHEM LIMITED with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronics & Computer Distribution · 157 stocks

Beats the industry median on 13/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 68 · Top 25%
Fair Value upside +195.5% · Top 25%
Profitability
Return on equity (12 months) 18.2% · Top 25%
Return on assets 6.8% · Top 25%
Net margin (12 months) 3.9% · Above median
Operating margin (12 months) 5.0% · Above median
Growth and dividend
Revenue growth (quarter YoY) 15.1% · Above median
Dividend yield (12 months) 15.1% · Top 25%

Valuation Multiplesvs Electronics & Computer Distribution median · lower = cheaper

P/E (12 months) 8.1× · Cheapest 25%
P/B 1.44× · Cheaper than median
P/S (12 months) 0.31× · Cheaper than median
Price / free cash flow (fiscal year) 4.8× · Cheapest 25%
EV/EBITDA 3.9× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 41
FUTURE (revenue growth)76 · sector 70
PAST (return on equity)73 · sector 41
HEALTH (low debt)100 · sector 97
DIVIDEND (yield)100 · sector 64

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Electronics & Computer Distribution stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
WPG Holdings 3702 82.40 TWD 144.03 TWD +75% vs AWZ
Shenzhen H&T Intelligent Control Co. 002402 ¥15.66 ¥20.12 +28% vs AWZ
TD SYNNEX Corporation SNX $237.58 $290.49 +22% vs AWZ
ALSO Holding ALSN CHF 198.40 CHF 224.18 +13% vs AWZ
Topco Scientific Co 5434 479.00 TWD 472.85 TWD −1% vs AWZ
Insight Enterprises, Inc NSIT $168.76 $142.01 −16% vs AWZ
Unisplendour Corporation 000938 ¥24.11 ¥18.06 −25% vs AWZ
Avnet, Inc AVT $83.97 $59.89 −29% vs AWZ
Arrow Electronics, Inc ARW $192.90 $96.88 −50% vs AWZ
Shenzhen Huaqiang Industry Co 000062 ¥20.88 ¥9.23 −56% vs AWZ

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

MULTI-CHEM LIMITED: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "MULTI-CHEM LIMITED Fair Value". https://www.fairvalue-calculator.com/stock/AWZ

Frequently asked questions

Is MULTI-CHEM LIMITED (AWZ) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of 7.18 SGD versus a price of 2.43 SGD, about +196% upside (undervalued).
What is the fair value of AWZ?
Our model-based fair value for MULTI-CHEM LIMITED is 7.18 SGD (as of Nov 14, 2026), built from audited fundamentals. The current price: 2.43 SGD.
What is the quality score of AWZ?
MULTI-CHEM LIMITED has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MULTI-CHEM LIMITED (AWZ)?
Our model-based price target is the fair value of 7.18 SGD (as of Nov 14, 2026) from 26 valuation models. Cautious scenario 5.64 SGD, optimistic scenario 8.70 SGD. It is a calculation from audited fundamentals, not an analyst target.
What is the MULTI-CHEM LIMITED stock forecast for 2026?
Our models put fair value at 7.18 SGD, about +196% upside versus a price of 2.43 SGD (undervalued). Cautious scenario 5.64 SGD, optimistic scenario 8.70 SGD. The calculation is refreshed regularly with new filings.
What is the revenue of MULTI-CHEM LIMITED (AWZ)?
MULTI-CHEM LIMITED reported trailing-twelve-month revenue of about 699M SGD (latest available figure, as of Nov 14, 2026).
What growth is priced into MULTI-CHEM LIMITED (AWZ)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at MULTI-CHEM LIMITED shrinks by 16.7 % per year for five years (discount rate 11.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 6.4 % per year. As of Nov 14, 2026.
What discount rate (WACC) does the fair value of AWZ use?
Our models discount MULTI-CHEM LIMITED at 11.0 %: a base by market capitalisation (micro), damped by beta 0.24, country premium for Singapore. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For MULTI-CHEM LIMITED that is -16.7 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.0 %) and the same formula as our fair value.
How much growth has MULTI-CHEM LIMITED (AWZ) delivered so far?
Over the past 5 years revenue at MULTI-CHEM LIMITED grew 6.4 % a year. The price currently implies free-cash-flow growth of -16.7 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of MULTI-CHEM LIMITED (AWZ) growing?
The median revenue growth in the sector is +12.0 % a year. That is the yardstick for the growth priced into MULTI-CHEM LIMITED (-16.7 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of MULTI-CHEM LIMITED (AWZ)?
The free-cash-flow yield on the price is 20.65 %: that much free cash flow MULTI-CHEM LIMITED produces per unit of market value. When it exceeds the discount rate of our models (11.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of MULTI-CHEM LIMITED (AWZ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MULTI-CHEM LIMITED it is 7.18 SGD per share (as of Nov 14, 2026), against a price of 2.43 SGD. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is MULTI-CHEM LIMITED stock overvalued or undervalued in 2026?
As of Nov 14, 2026, AWZ trades below its calculated fair value: price 2.43 SGD, fair value 7.18 SGD, a gap of about +196% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AWZ?
No. The price is what the market pays today (2.43 SGD); the fair value is what the company's own numbers justify (7.18 SGD). For MULTI-CHEM LIMITED the two are 4.75 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is MULTI-CHEM LIMITED worth?
The market values MULTI-CHEM LIMITED at about 219M SGD (market capitalisation, as of Nov 14, 2026). Per share that is 2.43 SGD; our models calculate a fair value of 7.18 SGD per share.
What do the bullish and bearish scenarios say about AWZ?
Our models span a range for MULTI-CHEM LIMITED: cautious scenario 5.64 SGD, base 7.18 SGD, optimistic 8.70 SGD per share (as of Nov 14, 2026, price 2.43 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AWZ?
MULTI-CHEM LIMITED trades at a price-to-earnings ratio of 8.1 (as of Nov 14, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 7.18 SGD is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 7.4. Other multiples: P/B 1.4, P/S 0.3, EV/EBITDA 3.9.
How solid is the balance sheet of MULTI-CHEM LIMITED (AWZ)?
Balance-sheet figures for MULTI-CHEM LIMITED (as of Nov 14, 2026): return on equity 18.2%. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is AWZ from its 52-week high?
MULTI-CHEM LIMITED trades at 2.43 SGD, about 46% below its 52-week high of 4.48 SGD and 23% above the low of 1.97 SGD (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of 7.18 SGD is for.
Which stocks are comparable to MULTI-CHEM LIMITED?
From the same area (Technology) we also value TD SYNNEX Corporation, Unisplendour Corporation, Arrow Electronics, Inc, Avnet, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MULTI-CHEM LIMITED stock attractive at the current price?
The data as of Nov 14, 2026: price 2.43 SGD, calculated fair value 7.18 SGD (+196%), Quality Score 68/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AWZ calculated?
We run MULTI-CHEM LIMITED through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 7.18 SGD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. MULTI-CHEM LIMITED currently trades 66% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MULTI-CHEM LIMITED (AWZ)?
The closing price on Nov 16, 2026 was 2.43 SGD. Our model-based fair value is 7.18 SGD, about +196% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MULTI-CHEM LIMITED right now?
The price is below even our cautious bear case (5.64 SGD). The market is more pessimistic than our downside scenario. Solid quality (68/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of MULTI-CHEM LIMITED

How large is the market capitalisation of MULTI-CHEM LIMITED (AWZ)?
The market capitalisation of MULTI-CHEM LIMITED is 219M SGD (≈ $170M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MULTI-CHEM LIMITED (AWZ)?
The price-to-sales ratio of MULTI-CHEM LIMITED is 0.31 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MULTI-CHEM LIMITED (AWZ)?
Earnings per share at MULTI-CHEM LIMITED are 0.3000 SGD (price ÷ EPS = P/E 8.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of MULTI-CHEM LIMITED (AWZ)?
The net margin of MULTI-CHEM LIMITED is 3.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MULTI-CHEM LIMITED (AWZ)?
The return on equity (ROE) of MULTI-CHEM LIMITED is 18.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MULTI-CHEM LIMITED (AWZ)?
On an EBIT basis the return on assets of MULTI-CHEM LIMITED is 8.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MULTI-CHEM LIMITED (AWZ)?
The operating margin of MULTI-CHEM LIMITED is 5.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MULTI-CHEM LIMITED (AWZ)?
Revenue at MULTI-CHEM LIMITED is growing 15.1% versus a year earlier (3y avg +2.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at MULTI-CHEM LIMITED (AWZ)?
Earnings per share at MULTI-CHEM LIMITED are growing 5.7% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch MULTI-CHEM LIMITED in the live analysis

One click puts MULTI-CHEM LIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.